Global Pharmaceutical Marijuana (MMJ) Market Research Report 2021

1 Pharmaceutical Marijuana (MMJ) Market Overview

• 1.1 Product Overview and Scope of Pharmaceutical Marijuana (MMJ)
• 1.2 Pharmaceutical Marijuana (MMJ) Segment by Type
  • 1.2.1 Global Pharmaceutical Marijuana (MMJ) Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 THC-dominant
  • 1.2.3 CBD-dominant
  • 1.2.4 Balanced THC & CBD
• 1.3 Pharmaceutical Marijuana (MMJ) Segment by Application
  • 1.3.1 Global Pharmaceutical Marijuana (MMJ) Sales Comparison by Application: (2021-2027)
  • 1.3.2 Cancer
  • 1.3.3 Arthritis
  • 1.3.4 Migraine
  • 1.3.5 Epilepsy
  • 1.3.6 Others
• 1.4 Global Pharmaceutical Marijuana (MMJ) Market Size Estimates and Forecasts
  • 1.4.1 Global Pharmaceutical Marijuana (MMJ) Revenue 2016-2027
  • 1.4.2 Global Pharmaceutical Marijuana (MMJ) Sales 2016-2027
  • 1.4.3 Pharmaceutical Marijuana (MMJ) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Pharmaceutical Marijuana (MMJ) Market Competition by Manufacturers

• 2.1 Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Pharmaceutical Marijuana (MMJ) Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Pharmaceutical Marijuana (MMJ) Manufacturing Sites, Area Served, Product Type
• 2.5 Pharmaceutical Marijuana (MMJ) Market Competitive Situation and Trends
  • 2.5.1 Pharmaceutical Marijuana (MMJ) Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Pharmaceutical Marijuana (MMJ) Players Market Share by Revenue
  • 2.5.3 Global Pharmaceutical Marijuana (MMJ) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pharmaceutical Marijuana (MMJ) Retrospective Market Scenario by Region

• 3.1 Global Pharmaceutical Marijuana (MMJ) Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Pharmaceutical Marijuana (MMJ) Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Pharmaceutical Marijuana (MMJ) Market Facts & Figures by Country
  • 3.3.1 North America Pharmaceutical Marijuana (MMJ) Sales by Country
  • 3.3.2 North America Pharmaceutical Marijuana (MMJ) Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Pharmaceutical Marijuana (MMJ) Market Facts & Figures by Country
  • 3.4.1 Europe Pharmaceutical Marijuana (MMJ) Sales by Country
  • 3.4.2 Europe Pharmaceutical Marijuana (MMJ) Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Pharmaceutical Marijuana (MMJ) Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Pharmaceutical Marijuana (MMJ) Sales by Region
  • 3.5.2 Asia Pacific Pharmaceutical Marijuana (MMJ) Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Pharmaceutical Marijuana (MMJ) Market Facts & Figures by Country
  • 3.6.1 Latin America Pharmaceutical Marijuana (MMJ) Sales by Country
  • 3.6.2 Latin America Pharmaceutical Marijuana (MMJ) Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa Pharmaceutical Marijuana (MMJ) Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Pharmaceutical Marijuana (MMJ) Sales by Country
  • 3.7.2 Middle East and Africa Pharmaceutical Marijuana (MMJ) Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Pharmaceutical Marijuana (MMJ) Historic Market Analysis by Type

• 4.1 Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2016-2021)
• 4.2 Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Type (2016-2021)
• 4.3 Global Pharmaceutical Marijuana (MMJ) Price by Type (2016-2021)

5 Global Pharmaceutical Marijuana (MMJ) Historic Market Analysis by Application

• 5.1 Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2016-2021)
• 5.2 Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Application (2016-2021)
• 5.3 Global Pharmaceutical Marijuana (MMJ) Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Canopy Growth Corporation
  • 6.1.1 Canopy Growth Corporation Corporation Information
  • 6.1.2 Canopy Growth Corporation Description and Business Overview
  • 6.1.3 Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Product Portfolio
  • 6.1.5 Canopy Growth Corporation Recent Developments/Updates
• 6.2 GW Pharmaceuticals, plc
  • 6.2.1 GW Pharmaceuticals, plc Corporation Information
  • 6.2.2 GW Pharmaceuticals, plc Description and Business Overview
  • 6.2.3 GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Product Portfolio
  • 6.2.5 GW Pharmaceuticals, plc Recent Developments/Updates
• 6.3 Aurora Cannabis, Inc.
  • 6.3.1 Aurora Cannabis, Inc. Corporation Information
  • 6.3.2 Aurora Cannabis, Inc. Description and Business Overview
  • 6.3.3 Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Product Portfolio
  • 6.3.5 Aurora Cannabis, Inc. Recent Developments/Updates
• 6.4 Aphria, Inc.
  • 6.4.1 Aphria, Inc. Corporation Information
  • 6.4.2 Aphria, Inc. Description and Business Overview
  • 6.4.3 Aphria, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Aphria, Inc. Pharmaceutical Marijuana (MMJ) Product Portfolio
  • 6.4.5 Aphria, Inc. Recent Developments/Updates
• 6.5 MedReleaf Corporation
  • 6.5.1 MedReleaf Corporation Corporation Information
  • 6.5.2 MedReleaf Corporation Description and Business Overview
  • 6.5.3 MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Product Portfolio
  • 6.5.5 MedReleaf Corporation Recent Developments/Updates
• 6.6 Insys Therapeutics, Inc.
  • 6.6.1 Insys Therapeutics, Inc. Corporation Information
  • 6.6.2 Insys Therapeutics, Inc. Description and Business Overview
  • 6.6.3 Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product Portfolio
  • 6.6.5 Insys Therapeutics, Inc. Recent Developments/Updates
• 6.7 CanniMed Therapeutics, Inc.
  • 6.6.1 CanniMed Therapeutics, Inc. Corporation Information
  • 6.6.2 CanniMed Therapeutics, Inc. Description and Business Overview
  • 6.6.3 CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product Portfolio
  • 6.7.5 CanniMed Therapeutics, Inc. Recent Developments/Updates
• 6.8 Cara Therapeutics, Inc.
  • 6.8.1 Cara Therapeutics, Inc. Corporation Information
  • 6.8.2 Cara Therapeutics, Inc. Description and Business Overview
  • 6.8.3 Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product Portfolio
  • 6.8.5 Cara Therapeutics, Inc. Recent Developments/Updates
• 6.9 United Cannabis Corporation
  • 6.9.1 United Cannabis Corporation Corporation Information
  • 6.9.2 United Cannabis Corporation Description and Business Overview
  • 6.9.3 United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Product Portfolio
  • 6.9.5 United Cannabis Corporation Recent Developments/Updates

7 Pharmaceutical Marijuana (MMJ) Manufacturing Cost Analysis

• 7.1 Pharmaceutical Marijuana (MMJ) Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Pharmaceutical Marijuana (MMJ)
• 7.4 Pharmaceutical Marijuana (MMJ) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Pharmaceutical Marijuana (MMJ) Distributors List
• 8.3 Pharmaceutical Marijuana (MMJ) Customers

9 Pharmaceutical Marijuana (MMJ) Market Dynamics

• 9.1 Pharmaceutical Marijuana (MMJ) Industry Trends
• 9.2 Pharmaceutical Marijuana (MMJ) Growth Drivers
• 9.3 Pharmaceutical Marijuana (MMJ) Market Challenges
• 9.4 Pharmaceutical Marijuana (MMJ) Market Restraints

10 Global Market Forecast

• 10.1 Pharmaceutical Marijuana (MMJ) Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Pharmaceutical Marijuana (MMJ) by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Pharmaceutical Marijuana (MMJ) by Type (2022-2027)
• 10.2 Pharmaceutical Marijuana (MMJ) Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Pharmaceutical Marijuana (MMJ) by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Pharmaceutical Marijuana (MMJ) by Application (2022-2027)
• 10.3 Pharmaceutical Marijuana (MMJ) Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Pharmaceutical Marijuana (MMJ) by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Pharmaceutical Marijuana (MMJ) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List